Dr. Reddys Laboratories informs about company updates

09 Nov 2017 Evaluate

Dr. Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended September 30, 2017, with the United States Securities and Exchange Commission on November 8, 2017.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1212.35 20.90 (1.75%)
09-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.35
Dr. Reddys Lab 1212.35
Cipla 1224.25
Zydus Lifesciences 902.15
Lupin 2296.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×